The management of pre-hypertension in primary care: Is it adequate?

被引:0
|
作者
Grossman, A. [1 ,2 ]
Ben-Assuli, Ofir [3 ]
Zelber-Sagi, S. [4 ,5 ]
Golbert, R. [2 ,6 ,7 ]
Matalon, A. [2 ,6 ,7 ]
Yeshua, H. [2 ,6 ,7 ]
机构
[1] Inst Endocrinol & Metab, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Ono Acad Coll, Fac Business Adm, Kiryat Ono, Israel
[4] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel
[5] Univ Haifa, Fac Social Welf & Hlth Sci, Sch Publ Hlth, IL-31999 Haifa, Israel
[6] Rabin Med Ctr, Clalit Hlth Serv, Petah Tiqwa, Israel
[7] Rabin Med Ctr, Dept Family Med, Petah Tiqwa, Israel
关键词
Hypertension; pre-hypertension; primary care; INSULIN-RESISTANCE; BLOOD-PRESSURE; HYPERTENSION; RISK; POPULATION; PREVALENCE; ADULTS; RELEVANCE; OBESITY;
D O I
10.3109/08037051.2015.1032515
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background. Pre-hypertension (pHT) is frequently diagnosed in the primary care setting, but its management by primary care physicians (PCPs) is not well characterized. Methods. All individuals aged 30-45 years who were insured by Clalit Health services in the Tel Aviv district and had their blood pressure (BP) measured from January 2006 to December 2010 were evaluated. Individuals were divided into three groups based on their initial BP value: optimal (<120/80 mmHg), normal (systolic BP 120-129 or diastolic 80-84 mmHg) and borderline (130-139/85-89 mmHg). Groups were compared regarding clinical and laboratory follow-up performed by their PCP. Results. Of the 20,214 individuals included in the study, 6576 (32.5%) had values in the pHT range. Of these, 2126 (32.3% of those with pHT) had BP values defined as "borderline" and 4450 (67.6% of those with pHT) had BP values defined as "normal". The number of follow-up visits by the PCP and repeat BP measurement were similar in those with "optimal" BP and pHT. A third and fourth BP measurement were recorded more frequently in those with pHT. In those with pHT, there were more recorded BP measurements than in those with borderline BP (3.35 +/- 3 vs 3.23 +/- 2.6), but the time from the initial to the second measurement and a record of a third and fourth measurement were the same in the two groups. Conclusion. Identification of pHT does not lead to a significant change in follow-up by PCPs, irrespective of BP values in the pHT range.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 50 条
  • [1] The management of pre-hypertension and metabolic syndrome
    Francesco, Pollice
    [J]. INTERNATIONAL CONFERENCE ON PRE-HYPERTENSION AND CARDIO METABOLIC SYNDROME (PREHT), 2011, : 75 - 78
  • [2] A review of the prevalence of primary aldosteronism in pre-hypertension and hypertension
    Piaditis, George
    Markou, Athina
    Papanastasiou, Labrini
    Androulakis, Ioannis I.
    Kaltsas, Gregory
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (05) : R191 - R203
  • [3] Pre-hypertension
    Shvartzman, P.
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (05): : 416 - 416
  • [4] Progression of Pre-hypertension
    Thomas D. Giles
    [J]. Current Hypertension Reports, 2011, 13 : 262 - 264
  • [5] Moxibustion in Pre-hypertension
    不详
    [J]. DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2020, 63 (01): : 47 - 47
  • [6] Progression of Pre-hypertension
    Giles, Thomas D.
    [J]. CURRENT HYPERTENSION REPORTS, 2011, 13 (04) : 262 - 264
  • [7] Hypertension & pre-hypertension in developing countries
    Pradeepa, R.
    Mohan, V.
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2008, 128 (06): : 688 - 690
  • [8] Development of Hypertension in Adolescents with Pre-Hypertension
    Redwine, Karen M.
    Acosta, Alisa A.
    Poffenbarger, Timothy
    Portman, Ronald J.
    Samuels, Joshua
    [J]. JOURNAL OF PEDIATRICS, 2012, 160 (01): : 98 - 103
  • [9] ADRENERGIC ACTIVITY IN PRE-HYPERTENSION
    KOTCHEN, TA
    GUTHRIE, GP
    MCKEAN, H
    KOTCHEN, JM
    [J]. CLINICAL RESEARCH, 1981, 29 (02): : A358 - A358
  • [10] Pre-hypertension: another 'pseudodisease’?
    Pascal Meier
    Franz H Messerli
    Andreas Baumbach
    Alexandra J Lansky
    [J]. BMC Medicine, 11